Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older von Dunkle, Lisa M, Izikson, Ruvim, Patriarca, Peter, Goldenthal, Karen L, Muse, Derek, Callahan, Janice, Cox, Manon M.J

Volltext

Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans von Nachbagauer, Raffael, Choi, Angela, Izikson, Ruvim, Cox, Manon M, Palese, Peter, Krammer, Florian

Volltext

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin von Rajendran, Madhusudan, Nachbagauer, Raffael, Ermler, Megan E, Bunduc, Paul, Amanat, Fatima, Izikson, Ruvim, Cox, Manon, Palese, Peter, Eichelberger, Maryna, Krammer, Florian

Volltext

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok® ) against influenza in healthy adults: A randomized, placebo-controlled trial von Treanor, John J, Sahly, Hana El, King, James, Graham, Irene, Izikson, Ruvim, Kohberger, Robert, Patriarca, Peter, Cox, Manon

Volltext

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans von Stadlbauer, Daniel, Rajabhathor, Arvind, Amanat, Fatima, Kaplan, Daniel, Masud, Abusaleh, Treanor, John J, Izikson, Ruvim, Cox, Manon M, Nachbagauer, Raffael, Krammer, Florian

Volltext

Safety and Immunogenicity of Flublok®, a Highly Purified Recombinant Recombinant Influenza Vaccine Made without Eggs or Live Influenza Viruses von Izikson, Ruvim, MD, Ibbitson, Elizabeth N., RN, Adams, Daniel, JD

Volltext

Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults von Cox, Manon M. J., Izikson, Ruvim, Post, Penny, Dunkle, Lisa

Volltext

Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a... von Izikson, Ruvim, Brune, Daniel, Bolduc, Jean-Sébastien, Bourron, Pierre, Fournier, Marion, Moore, Tamala Mallett, Pandey, Aseem, Perez, Lucia, Sater, Nessryne, Shrestha, Anju, Wague, Sophie, Samson, Sandrine I

Volltext

Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18–49 Years of Age von Dunkle, Lisa M., Izikson, Ruvim, Patriarca, Peter A., Goldenthal, Karen L., Muse, Derek, Cox, Manon M. J.

Volltext

Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyr... von Treanor, John J, Essink, Brandon, Hull, Steven, Reed, Steven, Izikson, Ruvim, Patriarca, Peter, Goldenthal, Karen L, Kohberger, Robert, Dunkle, Lisa M

Volltext

Safety of recombinant quadrivalent influenza vaccine compared to inactivated influenza vaccine in Chinese adults: An observational study von Hsiao, Amber, Hansen, John, Nunley, Karen Valdez, Lewis, Ned, Selmani, Alex, Inamdar, Ajinkya, Mallett-Moore, Tamala, Izikson, Ruvim, Rudin, Deborah, Klein, Nicola P.

Volltext

Safety and Immunogenicity of a Recombinant Influenza Vaccine: A Randomized Trial von Dunkle, Lisa M, Izikson, Ruvim, Patriarca, Peter A, Goldenthal, Karen L, Cox, Manon, Treanor, John J

Volltext

Safety of quadrivalent recombinant influenza vaccine in pregnant persons and their infants von Hsiao, Amber, Yee, Arnold, Izikson, Ruvim, Fireman, Bruce, Hansen, John, Lewis, Ned, Gandhi-Banga, Sonja, Selmani, Alexandre, Talanova, Oxana, Kabler, Heidi, Inamdar, Ajinkya, Klein, Nicola P.

Volltext

Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial von Treanor, John J, Chu, Laurence, Essink, Brandon, Muse, Derek, El Sahly, Hana M, Izikson, Ruvim, Goldenthal, Karen L, Patriarca, Peter, Dunkle, Lisa M

Volltext

Randomized comparison of the safety of Flublok® versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥50 years of age von Izikson, Ruvim, Leffell, David J, Bock, S. Allan, Patriarca, Peter A, Post, Penny, Dunkle, Lisa M, Cox, Manon M.J

Volltext

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study von Hansen, John, Goddard, Kristin, Timbol, Julius, Zhang, Lea, Lewis, Ned, Dunkle, Lisa, Izikson, Ruvim, Klein, Nicola P

Volltext

Randomized comparison of the safety of Flublok registered versus licensed inactivated influenza vaccine in healthy, medically stable adults greater than or equal to 50 years of age von Izikson, Ruvim, Leffell, David J, Bock, SAllan, Patriarca, Peter A, Post, Penny, Dunkle, Lisa M, Cox, Manon MJ

Volltext

SPIROMETRIC FEATURES OF PATIENTS WITH EXCESSIVE DYNAMIC EXPIRATORY CENTRAL AIRWAY COLLAPSE von Molina, Jaime L., Izikson, Ruvim, Sivashankar, Sivaraman, Sayal, Vikas, Shetty, Mahesh, Amoateng-Adyepong, Yaw, Horne, Joseph, Lvovsky, Dmitry

Volltext